Short interest for Right On Brands Inc gives investors a sense of the degree to which investors are betting on the decline of Right On Brands Inc's stock. Short interest data is updated every two weeks.

Right On Brands Inc Stock (OTC:RTOND), Short Interest Report

Right On Brands Inc

Trading Ideas

GameStop Shares Resuming Trade

EDBL

Edible Garden Shares Resume Trade

VirTra, Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VTSI#NASDAQ">VTSI</a>) shares are trading lower after the company reported&nbsp;<a target="_blank" href="https://www.benzinga.com/pressreleases/24/05/g38827841/virtra-reports-first-quarter-2024-financial-results" rel="noreferrer noopener">worse-than-expected first-quarter financial results</a>.
Revenue declined 19%&nbsp;year over year&nbsp;to $8.09 million, missing the consensus of $8.56 million&nbsp;due to&nbsp;delays in federal funding attributable to the U.S. government&#8217;s continuing resolution, which caused numerous contracts to be placed on hold.
CEO John Givens stated, &#8220;The anticipated revenue fluctuation was primarily due to the cyclical nature of budget allocations, often skewed towards year-end, coupled with the impact of the U.S. government&#8217;s continuing&nbsp;resolution,&nbsp;and the completion of a large portion of our capital backlog in 2023.&#8221;&nbsp;
Gross profit declined 21%&nbsp;Y/Y&nbsp;to $5.5 million in the quarter&nbsp;due to cost increases from the&nbsp;Microsoft Corporation&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) contract.&nbsp;
Adjusted EBITDA stood at $1.9 million in the quarter vs. $4.0 million a year ago. EPS of $0.11&nbsp;<a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener">missed the consensus of $0.12</a>.
As of March-end, cash and cash equivalents&nbsp;were $22.4 million.
CFO Alanna Boudreau stated, &#8220;Looking ahead, we remain focused on improving bookings performance and stabilizing backlog amidst order seasonality.&#8221;&nbsp;
&#8220;With strategic initiatives underway, particularly the launch of V-XR, we are positioning ourselves to improve our revenue growth for the remainder of 2024 compared to Q1. Our robust working capital shows our financial strength and supports strategic initiatives,&nbsp;<a target="_blank" href="https://www.benzinga.com/pressreleases/24/05/g38827841/virtra-reports-first-quarter-2024-financial-results" rel="noreferrer noopener">including scaled production of the V-XR.</a>&#8220;
Price Action:&nbsp;VTSI shares are down 30.8% at $11.36&nbsp;at the last check Wednesday.
Photo via Shutterstock

Earnings

Equities

News

Guidance

Small Cap

Movers

MSFT

VTSI

Why Is VirTra Stock Diving Today?

UBS analyst Shneur Gershuni maintains Energy Transfer (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ET#NYSE">ET</a>) with a Buy and raises the price target from $23 to $24.

Price Target

Analyst Ratings

UBS Maintains Buy on Energy Transfer, Raises Price Target to $24

Truist Securities analyst Joseph Civello maintains On Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ONON#NYSE">ONON</a>) with a Hold and raises the price target from $30 to $34.

ONON

Truist Securities Maintains Hold on On Holding, Raises Price Target to $34

Wedbush analyst Jay McCanless reiterates Meritage Homes (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTH#NYSE">MTH</a>) with a Underperform and maintains $148 price target.

Reiteration

Wedbush Reiterates Underperform on Meritage Homes, Maintains $148 Price Target

Truist Securities analyst Jake Bartlett maintains Jack In The Box (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JACK#NASDAQ">JACK</a>) with a Buy and lowers the price target from $99 to $83.

JACK

Truist Securities Maintains Buy on Jack In The Box, Lowers Price Target to $83

U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 200 points on Wednesday.
Following the market opening, the Dow traded up 0.54% to 39,772.77 while the NASDAQ rose 0.57% to 5,276.57. The S&amp;P 500 also rose, gaining, 0.59% to 16,608.83&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; .&nbsp; .
Check This Out: <a href="https://www.benzinga.com/news/24/05/38840839/wall-streets-most-accurate-analysts-views-on-3-materials-stocks-delivering-high-dividend-yields">Wall Street&#8217;s Most Accurate Analysts&#8217; Views On 3 Materials Stocks Delivering High-Dividend Yields</a>
Leading and Lagging Sectors Real estate shares rose by 1.8% on Wednesday.
In trading on Wednesday, energy shares fell by 0.5%.
Top Headline
U.S. consumer prices rose 0.3% month-over-month in April compared to 0.4% in the previous month, and also down from market expectations of 0.4%. Annual inflation rate in the U.S. slowed to 3.4% in April from 3.5% a month ago.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Sintx Technologies, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SINT#NASDAQ">SINT</a>) shares shot up 173% to $0.15 after jumping over 41% on Tuesday. SINTX Technologies recently posted downbeat quarterly results.</li>
<li>Shares of Edible Garden AG Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EDBL#NASDAQ">EDBL</a>) got a boost, surging 89% to $8.06 following first-quarter results.</li>
<li>Faraday Future Intelligent Electric Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FFIE#NASDAQ">FFIE</a>) shares were also up, gaining 75% to $0.4998 after jumping around 368% on Tuesday.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Virpax Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRPX#NASDAQ">VRPX</a>) shares dropped 63% to $0.85 after the company reported pricing of $2.25m public offering.</li>
<li>Shares of Yield10 Bioscience, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YTEN#NASDAQ">YTEN</a>) were down 49% to $2.69 after the company reported delisting from the Nasdaq.</li>
<li>Aethlon Medical, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEMD#NASDAQ">AEMD</a>) was down, falling 41% to $0.5050 after the company announced pricing of $4.7 million public offering.</li>
</ul>
Also Check This Out: <a href="https://www.benzinga.com/24/05/38840642/dell-to-rally-over-13-here-are-10-top-analyst-forecasts-for-wednesday">Dell To Rally Over 13%? Here Are 10 Top Analyst Forecasts For Wednesday</a>
Commodities In commodity news, oil traded down 0.5% to $77.63 while gold traded up 0.5% at $2,370.80.
Silver traded up 1.3% to $29.07 on Wednesday, while copper rose 2.1% to $4.9980.
Euro zone
European shares were mostly higher today. The eurozone's STOXX 600 rose 0.3%, Germany's DAX rose 0.5% and France's CAC 40 slipped 0.1%. Spain's IBEX 35 Index rose 0.5%, while London's FTSE 100 rose 0.5%.
Industrial production in the Eurozone increased by 0.6% month-over-month in March compared to a revised 1% gain in the previous month. The Eurozone economy grew by 0.3% on quarter during the first three months, compared to a 0.1% decline in the prior quarter.
The annual inflation rate in France fell to 2.2% in April from 2.3% in March.
Asia Pacific Markets
Asian markets closed mostly lower on Wednesday, with Japan's Nikkei gaining 0.08%, China's Composite Index falling 0.82%, Hong Kong's Hang Seng Index falling 0.22% and India's S&amp;P BSE Sensex falling 0.22%.
Total passenger vehicle sales in India rose 1.2% year-over-year to 287,746 in April compared to an 8.9% rise in the prior month. The People&#8217;s Bank of China kept the interest rate unchanged at 2.50%.
Economics
<ul>
<li>Mortgage applications in the US rose 0.5% from the prior week in the period ending May 10.</li>
<li>U.S. consumer prices rose 0.3% month-over-month in April compared to 0.4% in the previous month, and also down from market expectations of 0.4%.</li>
<li>Annual inflation rate in the U.S. slowed to 3.4% in April from 3.5% a month ago.</li>
<li>U.S. retail sales came in unchanged month-over-month in April compared to a revised 0.6% increase in March.</li>
<li>The NY Empire State Manufacturing Index declined to -15.6 in May compared to -14.3 in the prior month, and versus market estimates of -10.0.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/05/38839679/top-3-consumer-stocks-that-could-blast-off-this-month&quot;">Top 3 Consumer Stocks That Could Blast Off This Month</a>

Eurozone

Commodities

Intraday Update

Markets

AEMD

FFIE

SINT

VRPX

YTEN

Dow Jumps 200 Points; US Inflation Rate Slows In April

UBS analyst Robin Farley maintains DraftKings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DKNG#NASDAQ">DKNG</a>) with a Buy and raises the price target from $56 to $60.

DKNG

UBS Maintains Buy on DraftKings, Raises Price Target to $60

Truist Securities analyst Barry Jonas maintains Intl Game Tech (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IGT#NYSE">IGT</a>) with a Hold and lowers the price target from $26 to $23.

Truist Securities Maintains Hold on Intl Game Tech, Lowers Price Target to $23

Edible Garden Shares Resumed Trade Then Again Halted On Circuit Breaker To The Downside, Stock Now Up 53.2%

Editor&#8217;s note: This story has been updated with additional details. 
U.S. inflation data for April came in broadly in line with analyst estimates Wednesday, breaking a concerning three-month streak of higher-than-expected readings and reigniting hopes for a return to the Federal Reserve&#8217;s <a href="https://www.benzinga.com/topic/inflation">2% inflation target.</a>
Last month, the Consumer Price Index (CPI) showed a year-over-year increase of 3.4%.
Before the inflation report, traders expected the Fed to reduce interest rates by 50 basis points (two 25-basis-point cuts) by the end of the year, beginning in September. The benign April inflation report could further reinforce those expectations.
Simultaneously, the U.S. Census Bureau reported flat monthly growth in retail sales for April, sharply slowing from the downwardly revised 0.6% rise and missing the estimate of 0.4%. When excluding autos, retail sales advanced at a 0.2% pace, decelerating from the previous 0.9% increase but matching the expected 0.2% rise.
<h3 class="wp-block-heading">April CPI Report: Key Highlights</h3>
<ul>
<li>The headline CPI inflation rate surged by 3.4% in April compared to the same month last year, down from 3.5% in March and in line with the forecasted 3.4% increase.</li>
<li>On a monthly basis, headline CPI inflation increased by 0.3%, decelerating from the previous 0.4% and missing the predicted 0.4%.</li>
<li>Notably, gasoline experienced a 2.8% surge in April, accelerating from 1.5% in March.</li>
<li>Excluding energy and food, the core CPI inflation rate eased from 3.8% to 3.6% year-over-year, matching the expected 3.6%. It marks the lowest annual core inflation rate in three years. </li>
<li>On a monthly basis, core CPI inflation rose by 0.3%, slightly below the previous 0.4% but in line with estimates.</li>
<li>Shelter rose 0.4%, maintaining the same pace as in March.</li>
</ul>
<figure class="wp-block-table is-style-stripes"> 
<table>
<thead>
<tr>
<th>Category</th>
<th>April</th>
<th>Forecasted</th>
<th>March</th>
</tr>
</thead>
<tbody>
<tr>
<td>Headline CPI (YoY)</td>
<td>3.4%</td>
<td>3.4%</td>
<td>3.5%</td>
</tr>
<tr>
<td>Headline CPI (MoM)</td>
<td>0.3%</td>
<td>0.4%</td>
<td>0.4%</td>
</tr>
<tr>
<td>Core CPI (YoY)</td>
<td>3.6%</td>
<td>3.6%</td>
<td>3.8%</td>
</tr>
<tr>
<td>Core CPI (MoM)</td>
<td>0.3%</td>
<td>0.3%</td>
<td>0.4%</td>
</tr>
</tbody>
</table>
</figure>
<h3 class="wp-block-heading">Market Reactions: Yields, Dollar Drop, Stock Futures Jump</h3>
Immediate market reactions to the April inflation report saw Treasury yields easing across the board, with the rate-sensitive two-year yield retreating to 4.72%, crucially breaking below its 200-day moving average.
The U.S. dollar index (DXY), closely tracked by the Invesco DB USD Index Bullish Fund ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UUP#NYSE">UUP</a>), weakened by 0.5%.
Notably, the U.S. dollar weakened by over 0.7% against the Japanese yen. 
Futures on major U.S. equity indices turned to gains during premarket trading. Contracts on the S&amp;P 500 rose 0.3%, on track to hit fresh all-time highs at market open. 
Among the top 100 U.S. companies by market capitalization, Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) was the outperformer, up 2.2% in the premarket. Chipmaker giants Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) and Advanced Micro Devices Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) followed suit, both up by over 1%. 
The tech-heavy Nasdaq 100 index, tracked by the Invesco QQQ Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), closed at an all-time high on Wednesday and futures were 0.5% higher at 08:48 a.m. in New York. Contracts on the Russell 2000 were over 1% higher.
<h3 class="wp-block-heading">Chart of The Day: 2-Year Treasury Yields Tumble Below 200-Day Average As Inflation Slows To 3.4% In April</h3>
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="495" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/15085427/image-66-1024x495.png" alt="" class="wp-image-339359" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/15085427/image-66-1024x495.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/15085427/image-66-300x145.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/15085427/image-66-768x372.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/15085427/image-66-1536x743.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/15085427/image-66.png 1920w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read now: <a href="https://www.benzinga.com/news/earnings/24/05/38839147/wall-street-futures-pause-as-april-inflation-worries-eclipse-meme-stock-mania-2-0-why-this-analyst-">Wall Street Futures Pause As April Inflation Worries Eclipse Meme Stock Mania 2.0: Why This Analyst Bets May Will Be &#8216;Strong Month&#8217;</a>
Photo via Shutterstock.

Macro Economic Events

Macro Notification

Market Summary

Broad U.S. Equity ETFs

Treasuries

Econ #s

Economics

Federal Reserve

Tech

ETFs

NVDA

TSLA

PowerShares DB US Dollar Index Bullish Fund

US Inflation Falls As Expected In April, Bolsters Fed Rate Cut Bets (UPDATED)

JX Luxventure (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JXJT#NASDAQ">JXJT</a>) reported quarterly earnings of $0.50 per share. This is a 101.14 percent increase over losses of $(43.70) per share from the same period last year. The company reported $31.84 million in sales this quarter. This is a 60.14 percent decrease over sales of $79.88 million the same period last year.

JXJT

JX Luxventure FY EPS $0.50 Up From $(43.70) YoY, Sales $31.84M Down From $79.88M YoY

UBS analyst Damian Karas maintains Crane (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CR#NYSE">CR</a>) with a Neutral and raises the price target from $120 to $152.

UBS Maintains Neutral on Crane, Raises Price Target to $152

<ul>
<li>Ambry Genetics, a prominent leader in clinical genomic testing and a subsidiary of REALM IDx, Inc., along with PacBio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PACB#NASDAQ">PACB</a>), a leading developer of high-quality, highly accurate sequencing solutions, today announced their companies' selection by the University of California, Irvine (UCI) and the GREGoR Consortium (Genomics Research to Elucidate the Genetics of Rare diseases) to support the Pediatric Mendelian Genomics Research Center (MGRC) program to better understand the underlying biology of rare diseases.</li>
</ul>

PACB

Ambry Genetics And PacBio Selected By UCI And GREGoR Consortium To Support Pediatric Mendelian Genomics Research Center Program To Study Rare Diseases

Wedbush analyst Seth Basham reiterates AutoZone (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AZO#NYSE">AZO</a>) with a Outperform and maintains $3400 price target.

Wedbush Reiterates Outperform on AutoZone, Maintains $3400 Price Target

GameStop Shares Halted On Circuit Breaker On Circuit Breaker To The Downside, Stock Now Down -25.1%

Truist Securities analyst David Macdonald maintains Fresenius Medical Care (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMS#NYSE">FMS</a>) with a Hold and raises the price target from $21 to $24.

Truist Securities Maintains Hold on Fresenius Medical Care, Raises Price Target to $24

JX Luxventure (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JXJT#NASDAQ">JXJT</a>) reported quarterly earnings of $0.50 per share. This is a 101.14 percent increase over losses of $(43.70) per share from the same period last year.

JX Luxventure FY EPS $0.50 Up From $(43.70) YoY

Truist Securities analyst Michael Lewis maintains Elme Communities (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELME#NYSE">ELME</a>) with a Hold and raises the price target from $15 to $16.